Company Overview
ADMA BIOLOGICS, INC.
ADMARevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
510M
2025 FY
Net Income
147M
2025 FY
Shares Outstanding
238M
2025 FY
EPS
0.62USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1368514
Exchange
Nasdaq
Location
US